small molecule

NITROLINGUAL

NITROGLYCERIN

Loss of exclusivityloss of exclusivity
CompanyPOHL BOSKAMP

Drug detail

Brand nameNITROLINGUAL
Active ingredientNITROGLYCERIN
Strength0.4MG/SPRAY
Dosage formAEROSOL
RouteSUBLINGUAL
ModalitySmall molecule
FDA approvalOctober 1985
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

NITROLINGUAL patent cliff — loss of exclusivity — | CliffBio